Avidity Biosciences
RNA
#3198
Rank
ยฃ2.77 B
Marketcap
ยฃ23.05
Share price
-5.70%
Change (1 day)
10.24%
Change (1 year)

Avidity Biosciences (RNA) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ1.16 Billion

According to Avidity Biosciences's latest financial reports the company has ยฃ1.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Avidity Biosciences - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ1.19 B156.04%
2023-12-31ยฃ0.46 B-7.43%
2022-12-31ยฃ0.50 B68.03%
2021-12-31ยฃ0.30 B24.8%
2020-12-31ยฃ0.24 B233.78%
2019-12-31ยฃ72.12 M2862.87%
2018-12-31ยฃ2.43 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.88 B-24.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ7.24 M-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.04 B-9.77%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.40 B-65.53%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.21 B-81.41%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ15.83 B 1,263.77%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.60 B 210.40%๐Ÿ‡ฌ๐Ÿ‡ง UK